ÂÜÀòÂÒÂ×

Khemraj Hirani is the Chief Regulatory Officer at Ambulero.

Khemraj has 21 years of investigational drugs/biologics experience from bench to clinic. Principal strategic and regulatory consultant for clinical, scientific, and regulatory SME for the University of Miami Miller School of Medicine, PriZm Therapeutics, IGEA Pharma, Betalin Therapeutics, Eyepharma Inc, AAHRPP. Certified clinical (RPH), IRB (CIP), and Regulatory (RAC-US) professional dedicated to bringing novel therapies to market for unmet medical conditions.